“Gain of function” (GoF) research refers to genetic modification that deliberately enhances the abilities of an organism — often a virus or bacterium — to study how such changes affect its function, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Beta-blockers did not improve clinical outcomes after ...

The findings confirm the results of the CNIC-led REBOOT clinical trial and consolidate a paradigm shift in infarction treatment. A major analysis led by the Centro Nacional de Investigaciones ...

Autoantibodies for type 1 diabetes are markers of the immune system’s attack on beta cells. Testing for these autoantibodies – GAD, IA-2, IAA, ZnT8, and ICA – can help with monitoring and preparing ...

Among the foibles of Battlefield 6's record-breaking launch has been a frustrating bug causing extraneous bloom. For certain players, the reticle of their guns fails to re-center properly after firing ...

Type 2 diabetes (T2D) is a chronic and widely prevalent condition characterized by a progressive loss of glycemic control driven by both insulin resistance and β-cell dysfunction. The disease has long ...

24-year-old founder and CEO Carina Hong created Axiom Math in March 2025 and has recruited a team of ten employees, most of whom are from Meta, to build a math-focused AI model. Last fall, Carina Hong ...

Introduction Critically ill patients commonly develop acquired neutrophil dysfunction, which increases susceptibility to intensive care unit-acquired infection (ICU-AI). This study aimed to assess ...

A panelist discusses how preserving beta-cell function in type 1 diabetes (T1D) requires a multifaceted approach combining timely diagnosis, immunomodulatory therapies, optimal glycemic control and ...

A panelist discusses how type 1 diabetes (T1D) is a complex autoimmune disease characterized by progressive beta cell destruction that advances through distinct stages, with genetic predisposition, ...